Pfizer's Antiviral COVID-19 Pill Authorized by FDA

Video Credit: Wibbitz Top Stories
Published on December 22, 2021 - Duration: 01:30s

Pfizer's Antiviral COVID-19 Pill Authorized by FDA

Pfizer's Antiviral COVID-19 Pill , Authorized by FDA.

NPR reports the Food and Drug Administration has officially authorized the first COVID-19 antiviral pill.

The pill, Paxlovid, was created by pharmaceutical company Pfizer.

Experts say Pfizer's pill could keep those infected with COVID-19 from becoming ill enough to require hospitalization.

.

Experts say Pfizer's pill could keep those infected with COVID-19 from becoming ill enough to require hospitalization.

.

According to NPR, the pill is meant to be ingested twice a day for five days.

Paxlovid will reportedly require a tandem dose of generic antiviral medicine ritonavir.

Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill — a major step forward in the fight against this global pandemic.

, Dr. Patrizia Cavazzoni, director of the FDA Center for Drug Evaluation and Research, via NPR.

Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill — a major step forward in the fight against this global pandemic.

, Dr. Patrizia Cavazzoni, director of the FDA Center for Drug Evaluation and Research, via NPR.

Pfizer's studies suggest taking Paxlovid within three days of exhibiting symptoms could reduce the risk of death and hospitalization by 89%.

Pfizer's studies suggest taking Paxlovid within three days of exhibiting symptoms could reduce the risk of death and hospitalization by 89%.

NPR reports separate studies showed the pill only reduced 70% of hospitalizations.

Experts say the effectiveness of Paxlovid shouldn't diminish when treating Omicron-related infections.

The United States will reportedly purchase 10 million courses of Pfizer's new COVID-19 treatment.

Pfizer says around 180,000 courses of treatment will be available by the end of the year


You are here


💡 newsR Knowledge: Other News Mentions


COVID-19

Contagious disease caused by SARS-CoV-2
Monkeypox may be less transmittable than COVID, but the virus is exploding and most folks aren't immune to its effects ... so says, Dr. Eric Feigl-Ding. The..
Credit: TMZ.com - Published 5 hours ago

The US Food and Drug Administration (USFDA) has lifted the clinical hold on the Phase 2 and 3 immuno-bridging clinical trials of Bharat Biotech’s Covid-19..
Credit: IndiaTimes - Published 11 hours ago

Monkeypox is a "particularly nasty virus" and it is "important we get it under control" - but it only poses a "very low" threat to the wider public and is not..
18 hours ago • Sky News



Related videos from verified sources

Pfizer's COVID Pill Protects Against Omicron Variant, New Study Finds 01:30
Video credit: Wibbitz Top Stories - Published on December 14, 2021 

Pfizer says Covid-19 pill almost 90% effective against severe infection | Paxlovid | Oneindia News 02:05
Video credit: Oneindia - Published on December 14, 2021 

FDA Advisers Narrowly Endorse Merck’s COVID Antiviral Pill 01:30
Video credit: Wibbitz Top Stories - Published on December 1, 2021 

You might like